Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Blue Sky Uranium Expands Drill Plan to Advance the Ivana Uranium-Vanadium Project (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Schrodinger Inc SDGR

Technology Software - Application
Schrodinger, Inc. operates a physics-based computational platform that enables the discovery of molecules for drug development and materials applications. The software platform is used by biopharmaceutical and industrial companies, academic institutions, and government laboratories around the world. Its segments include Software and Drug Discovery. The Software segment is focused on selling its... see more

Recent & Breaking News (NDAQ:SDGR)

Schrödinger Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Business Wire January 20, 2022

Schrödinger Announces Acquisition of XTAL BioStructures, Inc.

Business Wire January 18, 2022

Schrödinger to Present at H.C. Wainwright BioConnect Conference

Business Wire January 5, 2022

Schrödinger Announces Retirement of Chief Financial Officer Joel Lebowitz

Business Wire December 21, 2021

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Business Wire December 20, 2021

Schrödinger Reports Preclinical Data Supporting Advancement Of Its MALT1 Inhibitor Program At American Society Of Hematology 2021 Annual Meeting

Business Wire December 11, 2021

Schrödinger to Participate in Five Upcoming Investor Conferences

Business Wire November 22, 2021

Schrödinger Awarded Grant to Accelerate Drug Discovery in Women's Health

Business Wire November 18, 2021

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Business Wire November 17, 2021

Schrödinger Reports Third Quarter 2021 Financial Results and Provides Company Update

Business Wire November 10, 2021

Schrödinger to Present at Jefferies London Healthcare Conference

Business Wire November 9, 2021

Schrödinger to Present New Preclinical Data From Its MALT1 Inhibitor Program at ASH 2021 Annual Meeting

Business Wire November 4, 2021

Schrödinger to Host Conference Call to Discuss Third Quarter 2021 Financial Results

Business Wire October 29, 2021

Centessa Pharmaceuticals Subsidiary, Orexia Therapeutics, and Schrödinger Announce Collaboration to Discover Novel Orexin Receptor Agonists

GlobeNewswire October 18, 2021

Schrödinger Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Business Wire October 18, 2021

MD Anderson and Schrödinger Announce Strategic Research Collaboration to Accelerate Development of WEE1 Program

Business Wire October 7, 2021

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Business Wire September 22, 2021

Schrödinger to Present at Four Investor Conferences in September

Business Wire September 3, 2021

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Business Wire August 18, 2021

Schrödinger Announces Closing of Initial Public Offering

Business Wire February 10, 2020